BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 35149119)

  • 1. Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas.
    Sarkadi B; Meszaros K; Krencz I; Canu L; Krokker L; Zakarias S; Barna G; Sebestyen A; Papay J; Hujber Z; Butz H; Darvasi O; Igaz P; Doczi J; Luconi M; Chinopoulos C; Patocs A
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of SDHB Induces a Metabolic Switch in the hPheo1 Cell Line toward Enhanced OXPHOS.
    Tabebi M; Kumar Dutta R; Skoglund C; Söderkvist P; Gimm O
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical picture: SDHD paraganglioma presenting with syncope.
    LaChance DP; Hoang TD; Shakir MKM
    Clin Case Rep; 2021 Feb; 9(2):1031-1032. PubMed ID: 33598293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
    Pamporaki C; Berends AMA; Filippatos A; Prodanov T; Meuter L; Prejbisz A; Beuschlein F; Fassnacht M; Timmers HJLM; Nölting S; Abhyankar K; Constantinescu G; Kunath C; de Haas RJ; Wang K; Remde H; Bornstein SR; Januszewicz A; Robledo M; Lenders JWM; Kerstens MN; Pacak K; Eisenhofer G
    Lancet Digit Health; 2023 Sep; 5(9):e551-e559. PubMed ID: 37474439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour microenvironment in pheochromocytoma and paraganglioma.
    Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
    Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metabolic cancer therapy on tumor microenvironment.
    Hyroššová P; Milošević M; Škoda J; Vachtenheim J; Rohlena J; Rohlenová K
    Front Oncol; 2022; 12():1046630. PubMed ID: 36582801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts.
    Martinelli S; Amore F; Mello T; Mannelli M; Maggi M; Rapizzi E
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
    MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism.
    Martinelli S; Riverso M; Mello T; Amore F; Parri M; Simeone I; Mannelli M; Maggi M; Rapizzi E
    Mol Cell Endocrinol; 2022 May; 547():111594. PubMed ID: 35149119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microenvironment induces collective migration in
    D'Antongiovanni V; Martinelli S; Richter S; Canu L; Guasti D; Mello T; Romagnoli P; Pacak K; Eisenhofer G; Mannelli M; Rapizzi E
    Endocr Relat Cancer; 2017 Oct; 24(10):555-564. PubMed ID: 28830936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
    J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.